geldding2 schreef op 19 maart 2018 14:19:
Product Pricing and Cost Structure:
The plasma industry’s cost structure differs from the traditional pharmaceutical or biotechnology industries. The cost of plasma – the plasma industry’s raw material – is much higher than the cost of raw materials used in the traditional pharmaceutical or biotechnology industry to make therapies. Plasma is expensive because only small quantities of plasma may be collected from donors at a time. Therefore, many donors are needed by the companies, and they have to donate plasma frequently. Furthermore, collecting plasma is a complicated and delicate operation, involving expensive plasmapheresis equipment and highly qualified staff. Consequently, plasma, the raw material, represents roughly 25-50% of the total cost to produce plasma-based therapeutic proteins, and as a result, they are relatively expensive. Furthermore, the fractionation process is complex and expensive
marketingresearchbureau.com/plasma-in...